The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Blood, lymphoma & myeloma

Blood cancer is a type of malignancy that affects the hematopoietic (= blood cell forming) system. Leukemia, lymphoma and myeloma are some of the most common types of blood cancer which arise from the blood forming bone marrow including the lymphatic system. In Sweden about 4500 new cases of blood cancer are diagnosed every year.

The LUCC-Blood network is one of the largest cancer research areas at Lund University. LUCC-Blood comprises over 20 research groups, which are mostly located in Lund. The scientific focus areas span from basic science to clinical studies, with major research projects within stem cell biology, genomics, genetics, cell signaling, biomarkers, tumor microenvironment, immunology, diagnostics, epidemiology, and anti-cancer therapies.

Blood cancer research at Lund University is world-renown for its high-quality basic and translational research and long-standing expertise in clinical trials, high-throughput methods, and functional in-vivo model systems. Some of the main research questions that blood cancer researchers at Lund University are trying to address include the origin of hematopoietic malignancies and their microenvironment, genetic predisposition and markers of disease diagnosis and progression, as well as the development of novel gene- and blood cell-based anti-cancer immune therapies.

The purpose of the LUCC-Blood network is to:

  • provide a platform for our blood cancer researchers to meet and connect. This will lead to an active exchange of ideas and technologies and increased collaboration. 
  • The ultimate goal, of course, is to improve the outcomes and quality of life of patients with malignant diseases of the hematopoietic system.

The LUCC-Blood network organizes regular seminars, symposia, invite speakers, and coordinate other scientific activities (see LUCC calendar). To learn more, contact the co-leaders Anna or Stefan.

Network leaders

Anna Hagström, photo

Anna Hagström

Anna [dot] Hagstrom [at] med [dot] lu [dot] se (Anna[dot]Hagstrom[at]med[dot]lu[dot]se)
+46 46 222 69 97

Department of Laboratory Medicine
Lund University
BMC D14 
22184 Lund


Stefan Scheding, photo

Stefan Scheding

Stefan [dot] Scheding [at] med [dot] lu [dot] se
+46 46 222 33 31

Department of Laboratory Medicine
Lund University
22184 Lund